Hemodynamic effects of the arteriolar vasodilators hydralazine, dihydralazine and endralazine in the conscious spontaneously hypertensive rat
- 1 November 1983
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 95 (3-4) , 151-159
- https://doi.org/10.1016/0014-2999(83)90629-5
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Endralazine, a New Peripheral Vasodilator—a Randomized Cross-Over Trial Against DihydralazineJournal of Cardiovascular Pharmacology, 1982
- Clinical Evaluation of Endralazine (BQ22708), A New Vasodilator, in Essential HypertensionClinical and Experimental Hypertension. Part A: Theory and Practice, 1982
- Production of sustained hypertension by lesions in the nucleus tractus solitarii of the American foxhound.Hypertension, 1979
- Increased levels of prostaglandin-like material in the canine blood during arterial hypotension produced by hydralazine, dihydralazine and minoxidilNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1979
- Need for beta-blockade in hypertension reduced with long-term minoxidil.BMJ, 1978
- Direct and reflex cardiostimulating effects of hydralazineThe American Journal of Cardiology, 1977
- Regional and Systemic Hemodynamic Patterns in Rabbits with Neurogenic HypertensionCirculation Research, 1974
- Vasodilator drugs in the treatment of hypertensionArchives of internal medicine (1960), 1974
- Mechanisms of Contraction of the Normal and Failing HeartNew England Journal of Medicine, 1967
- Neurogenic Hypertension in the RatCirculation Research, 1964